Article
Engineering an RNA-based tissue-specific platform for genetic editing through use of a miRNA-enabled Cas12a
2020-03-05
Abstract excerpt
<h4>ABSTRACT</h4> The capacity to edit genomes using CRISPR-Cas systems holds immense potential for countless genetic-based diseases. However, one significant impediment preventing broad therapeutic utilization is in vivo delivery. While genetic editing at a single cell level in vitro can be achieved with high efficiency, the capacity to utilize these same biologic tools in a desired tissue in vivo remains cha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 227ced50-6072-549b-abb5-41b6757af35a
- DOI
- 10.1101/2020.03.04.977363
